HANSIZHUANG (serplulimab) is the world\'s first anti-PD-1 mAb for first-line treatment of ES-SCLC - HANSIZHUANG (serplulimab) is expected to become the first and only anti-PD-1 monoclonal antibody ava
Continuously expanding webmaster signups,especially in multiple regions,along with new highs in webmaster payouts,has ensured the smooth operation and continuous development of the project.
SHANGHAI,Sept. 23,2024-- At HUAWEI CONNECT 2024,Huawei successfully held the optical summit themed "Accelerate F5G-A,Amplify Intelligence". At the summit,Huawei launched new F5G Advanced (F5
HMSDK,a proprietary memory control solution lauded for its performance,is now available on Linux,the world\'s largest open source operating system
LONDON,Sept. 23,2024-- The opening of the Odyssey 2024 film festival and the Odyssey Sustainability Film Awards (Odyssey SFA) presentation took place on Monday evening,16thof September,at the Ritzy Pi
NuancePharma successfully launched Bentrio® nasal spray for protection against airborne particles in Hong Kong and filed request for marketing authorization for Mainland China
